Catalyst Wire Dossier Catalyst Wire Dossier

Tegafur, Gimeracil and Oteracil Potassium

tegafur/gimeracil/oteracil potassium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tegafur, Gimeracil and Oteracil Potassium, covering 2020-03-19 to 2020-03-19. Get the full timeline:

Most recent: Clinical Trial Update: CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer [Phase 1, Phase 2]

See pricing